Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-05-31 Lynx1 Capital Management LP 10% owner Sale −10,000 $2.51 $25K 5,240,000
2023-05-31 Lynx1 Capital Management LP 10% owner Sale −15,000 $2.52 $38K 5,225,000
2023-05-31 Lynx1 Capital Management LP 10% owner Sale −400 $2.51 $1K 5,224,600
2023-04-06 Klencke Barbara Director Grant or award · Stock Option (Right to Buy) +9,146 9,146
2023-02-02 ZDRAVESKI ZORAN Chief Legal Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2023-02-02 SOUTHWELL DAVID P Chief Executive Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2023-02-02 MacBeath Gavin See Remarks Grant or award · Stock Option (Right to Buy) +40,000 40,000
2023-02-02 Barton Debora Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-12-28 Silver Brian M. Chief Financial Officer Purchase +3,158 $1.56 $5K 32,885
2022-12-27 Silver Brian M. Chief Financial Officer Purchase +2,842 $1.50 $4K 29,727
2022-07-25 SOUTHWELL DAVID P Chief Executive Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-07-25 Desmarais William Chief Business Officer Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-07-25 ZDRAVESKI ZORAN Chief Legal Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-07-25 Silver Brian M. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +220,000 220,000
2022-07-25 MacBeath Gavin See Remarks Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-07-05 Barton Debora Chief Medical Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2022-06-01 BAKER BROS. ADVISORS LP Director Grant or award · Non- Qualified Stock Option (right to buy) +9,146 9,146
2022-06-01 Gruia Gabriela Director Grant or award · Stock Option (Right to Buy) +9,146 9,146
2022-06-01 BARBERICH TIMOTHY J Director Grant or award · Stock Option (Right to Buy) +9,146 9,146
2022-06-01 Dorton Katina Director Grant or award · Stock Option (Right to Buy) +9,146 9,146

Page 5 of 8 · 144 trades